These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6348681)

  • 41. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
    Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
    Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Transfusion strategy for patients in therapeutic aplasia. Experience of the Henri Mondor Hospital apropos of 2 successive protocols].
    Bierling P; Lecollier B; Cordonnier C; Wallet P; Rodet M; Duedari N
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):249-64. PubMed ID: 2832926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet component transfusion and alloimmunization: Where do we stand?
    Moncharmont P
    Transfus Clin Biol; 2018 Sep; 25(3):172-178. PubMed ID: 29478960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
    De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
    Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
    Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
    J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of leukocyte-free platelets for transfusion by filtration through cotton wool.
    Sirchia G; Parravicini A; Rebulla P; Bertolini F; Morelati F; Marconi M
    Vox Sang; 1983; 44(2):115-20. PubMed ID: 6829183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet transfusion therapy.
    Aisner J
    Med Clin North Am; 1977 Sep; 61(5):1133-45. PubMed ID: 330975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelets possessing class I and/or class II MHC molecules.
    Pócsik E; Mihalik R; Réti M; Gyódi E; Pálóczi K; Mayer K; Kassai M; Herold M; Huber C; Petrányi GG
    Immunobiology; 1990 Dec; 182(1):22-31. PubMed ID: 1983002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Thrombocyte crossmatching: clinical experience with the Capture P-test].
    Böck M; Heim MU; Schleich I; Weindler R; Mepel W
    Beitr Infusionsther; 1990; 26():150-2. PubMed ID: 1703817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
    BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experiences in thrombocyte substitution following bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen D; Mahmoud HK; Schmidt CG
    Beitr Infusionther Klin Ernahr; 1986; 15():165-71. PubMed ID: 3530241
    [No Abstract]   [Full Text] [Related]  

  • 54. A practical guide to granulocyte transfusion therapy.
    Russell JA; Powles RL
    J Clin Pathol; 1976 May; 29(5):369-79. PubMed ID: 58873
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention of platelet transfusion refractoriness and HLA alloimmunization by leukocyte filtered platelet transfusion: a meta analysis].
    Yuan Q; Chen X; Cheng L; Zhou CH; Fu XM; Li YP; Wang NH; Wang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):412-20. PubMed ID: 21906451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing.
    Rachel JM; Summers TC; Sinor LT; Plapp FV
    Am J Clin Pathol; 1988 Jul; 90(1):63-8. PubMed ID: 3389344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How do I … manage the platelet transfusion-refractory patient?
    Juskewitch JE; Norgan AP; De Goey SR; Duellman PM; Wakefield LL; Gandhi MJ; Stubbs JR; Kreuter JD
    Transfusion; 2017 Dec; 57(12):2828-2835. PubMed ID: 28960321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of filtration in the provision of leukocyte poor red cells to multitransfused patients.
    James J; Matthews RN; Holdsworth RF; Fulton A; Tauro GP; Hussein S; McGrath KM
    Pathology; 1986 Jan; 18(1):127-30. PubMed ID: 3725421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.